Bharwani L - Search Results

1

Pemetrexed in the treatment of thoracic malignancies: a single centre experience in Singapore.

Lopes G, Chopra A, Kukutschka J, Portillo P, Bharwani L, Chang A. Lopes G, et al. Among authors: bharwani l. Singapore Med J. 2011 Mar;52(3):190-4. Singapore Med J. 2011. PMID: 21451928 Free article.

2

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Ali R, Toh HC, Chia WK; ASCOLT Trial Investigators. Ali R, et al. Trials. 2011 Dec 14;12:261. doi: 10.1186/1745-6215-12-261. Trials. 2011. PMID: 22168568 Free PMC article. Clinical Trial.

3

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Verma A, Chopra A, Lee YW, Bharwani LD, Asmat AB, Aneez DB, Akbar FA, Lim AY, Chotirmall SH, Abisheganaden J. Verma A, et al. Among authors: bharwani ld. Curr Drug Discov Technol. 2016;13(2):68-76. doi: 10.2174/1570163813666160524142846. Curr Drug Discov Technol. 2016. PMID: 27216707 Free PMC article.

4

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.

Lee SC, Shimasaki N, Lim JSJ, Wong A, Yadav K, Yong WP, Tan LK, Koh LP, Poon MLM, Tan SH, Ow SGW, Bharwani L, Yap YS, Foo MZQ, Coustan-Smith E, Sundar R, Tan HL, Chong WQ, Kumarakulasinghe NB, Lieow JLM, Koe PJX, Goh BC, Campana D. Lee SC, et al. Among authors: bharwani l. Clin Cancer Res. 2020 Sep 1;26(17):4494-4502. doi: 10.1158/1078-0432.CCR-20-0768. Epub 2020 Jun 10. Clin Cancer Res. 2020. PMID: 32522887 Clinical Trial.

5

Paraneoplastic Necrotizing Myelopathy in a Patient With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Lee CH, Bharwani L, Sullivan T. Lee CH, et al. Among authors: bharwani l. World J Oncol. 2011 Aug;2(4):195-198. doi: 10.4021/wjon279w. Epub 2011 Aug 24. World J Oncol. 2011. PMID: 29147247 Free PMC article.

6

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.

Low JL, Lim E, Bharwani L, Wong A, Wong K, Ow S, Lim SE, Lee M, Choo J, Lim J, Chan G, Walsh RJ, Muthu V, Ngoi N, Chong W, Tan SH, Lee SC. Low JL, et al. Among authors: bharwani l. Ther Adv Med Oncol. 2022 Dec 18;14:17588359221139678. doi: 10.1177/17588359221139678. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36570409 Free PMC article.

7

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Huang Y, Zhao JJ, Soon YY, Kee A, Tay SH, Aminkeng F, Ang Y, Wong ASC, Bharwani LD, Goh BC, Soo RA. Huang Y, et al. Among authors: bharwani ld. Cancers (Basel). 2023 May 12;15(10):2733. doi: 10.3390/cancers15102733. Cancers (Basel). 2023. PMID: 37345072 Free PMC article.

8

COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study.

Tan WC, Tan JYJ, Lim JSJ, Tan RYC, Lee ARYB, Leong FL, Lee SC, Chai LYA, Tan TT, Malek MIBA, Ong B, Lye DC, Chiew CJ, Chng WJ, Lim ST, Bharwani LD, Tan IB, Sundar R, Tan KB. Tan WC, et al. Among authors: bharwani ld. JAMA Oncol. 2023 Sep 1;9(9):1221-1229. doi: 10.1001/jamaoncol.2023.2271. JAMA Oncol. 2023. PMID: 37440245 Free PMC article.

9

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.

Tay SH, Toh MMX, Thian YL, Vellayappan BA, Fairhurst AM, Chan YH, Aminkeng F, Bharwani LD, Huang Y, Mak A, Wong ASC. Tay SH, et al. Among authors: bharwani ld. Front Immunol. 2022 Jan 28;13:807050. doi: 10.3389/fimmu.2022.807050. eCollection 2022. Front Immunol. 2022. PMID: 35154124 Free PMC article. Review.

10

Impact of cytochrome P450 2D6 polymorphisms on decision-making and clinical outcomes in adjuvant hormonal therapy for breast cancer.

Tan EY, Bharwani L, Chia YH, Soong RCT, Lee SSY, Chen JJC, Chan PMY. Tan EY, et al. Among authors: bharwani l. World J Clin Oncol. 2022 Aug 24;13(8):712-724. doi: 10.5306/wjco.v13.i8.712. World J Clin Oncol. 2022. PMID: 36160461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters